Novel and emerging treatments for Aicardi-Goutières syndrome

D Tonduti, E Fazzi, R Badolato… - Expert Review of Clinical …, 2020 - Taylor & Francis
ABSTRACT Introduction: Aicardi-Goutières syndrome (AGS) is the prototype of the type I
interferonopathies, a new heterogeneous group of autoinflammatory disorders in which type …

Emerging paramyxoviruses: molecular mechanisms and antiviral strategies

HC Aguilar, B Lee - Expert reviews in molecular medicine, 2011 - cambridge.org
In recent years, several paramyxoviruses have emerged to infect humans, including
previously unidentified zoonoses. Hendra and Nipah viruses (henipaviruses within this …

LYC inhibits the AKT signaling pathway to activate autophagy and ameliorate TGFB-induced renal fibrosis

Y Wang, Z Ping, H Gao, Z Liu, Q Xv, X Jiang, W Yu - Autophagy, 2024 - Taylor & Francis
Renal fibrosis is a typical pathological change in chronic kidney disease (CKD). Epithelial-
mesenchymal transition (EMT) is the predominant stage. Activation of macroautophagy …

Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase

A Capell, S Liebscher, K Fellerer… - Journal of …, 2011 - Soc Neuroscience
Numerous loss-of-function mutations in the progranulin (GRN) gene cause frontotemporal
lobar degeneration with ubiquitin and TAR–DNA binding protein 43-positive inclusions by …

Discovery of new classes of compounds that reactivate acetylcholinesterase inhibited by organophosphates

FS Katz, S Pecic, TH Tran, I Trakht, L Schneider… - …, 2015 - Wiley Online Library
Acetylcholinesterase (AChE) that has been covalently inhibited by organophosphate
compounds (OPCs), such as nerve agents and pesticides, has traditionally been reactivated …

The chronic adverse effect of chloroquine on kidney in rats through an autophagy dependent and independent pathways

B Wang, H Guo, L Ling, J Ji, J Niu, Y Gu - Nephron, 2020 - karger.com
Background: Chloroquine (CQ), a classic autophagy inhibitor, is used clinically for malaria
prophylaxis and pulmonary hypertension treatment. The adverse effects of CQ on …

Charakterystyka wirusa SARS-CoV-2 i potencjalne farmakologiczne sposoby leczenia

L Pawlik, E Śpiołek, J Fichna… - Postępy …, 2020 - publicum.umed.lodz.pl
STRESZCZENIE W grudniu 2019 r. w Chinach odnotowano pierwsze przypadki zapalania
płuc spowodowane zakażeniem nieznanym dotychczas koronawirusem, który ze względu …

Hendra and Nipah infection: pathology, models and potential therapies

F Vigant, B Lee - … -Drug Targets (Formerly Current Drug Targets …, 2011 - ingentaconnect.com
The Paramyxoviridae family comprises of several genera that contain emerging or re-
emerging threats for human and animal health with no real specific effective treatment …

Chloroquine enhances replication of influenza A virus A/WSN/33 (H1N1) in dose‐, time‐, and MOI‐dependent manners in human lung epithelial cells A549

L Wu, J Dai, X Zhao, Y Chen… - Journal of Medical …, 2015 - Wiley Online Library
Anti‐malaria drug, chloroquine, has been reported to be effective against influenza A virus
(IAV) in vitro and used in in‐vivo experiments and clinical trial for prevention or treatment of …

Single-chain variable fragment technology in forensic toxicological analysis: production of an antibody to fluvoxamine

A Sasao, Y Suwa, T Aso, H Kohmatsu, Y Ohtsu… - Forensic …, 2013 - Springer
Immunoassay techniques are widely used for drug screening in the fields of forensic
toxicology and emergency medicine, because of their simple procedures and rapid outcome …